Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
FEBS Lett ; 586(23): 4186-9, 2012 Nov 30.
Artículo en Inglés | MEDLINE | ID: mdl-23098756

RESUMEN

O-Aryloxycarbonyl hydroxamates and 1,3,4-oxathiazol-2-ones have been identified as covalent inhibitors of ß-lactamases and proteasomes, respectively. The products of these inhibition reactions are remarkably similar, involving carbonyl cross-linking of the active sites. We have cross-checked these inhibitors, showing that the former inhibit proteasomes and the latter ß-lactamases, to form the same inactive carbonyl adducts. These results are discussed in terms of similarities of the active site structures and catalytic mechanisms. It is likely that a mechanistic imperative has led to convergent evolution of these enzyme active sites, of a ß-lactam-recognizing enzyme and a N-terminal protease belonging to different amidohydrolase superfamilies.


Asunto(s)
Amidohidrolasas/antagonistas & inhibidores , Amidohidrolasas/química , Evolución Molecular , Inhibidores de beta-Lactamasas , beta-Lactamasas/química , Dominio Catalítico , Inhibidores Enzimáticos/farmacología , Complejo de la Endopetidasa Proteasomal/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...